Abstract
absence of haematuria and of histological/serological evid-graphic method ) [9] , as were mean clinic BP recordings. No patient received a low protein diet during the study period. ence of non-diabetic renal disease, progressive impairment of renal function and regular follow-up in the diabetes/renal
The values of DCrCl, clinic BP, Ghb and ambulatory BP recordings were compared between the dipper and clinic. Eight other patients were debarred from inclusion as they had overt signs of renovascular disease, all proven on non-dipper group. Mann-Whitney U tests were used for comparison between the two groups. The DCrCl was calcurenal angiography. All patients were non-smokers (a strict no-smoking campaign with regular re-inforcement is in lated using a linear regression analysis. Level of significance was set at two-tailed P<0.05. operation in the clinic) and on no dietary restrictions at any stage except those relevant to diabetes. At each visit, serum creatinine, weight, BP, urine analysis, glycated haemoglobin (GHb), blood sugar and a record of anti-hypertensive medication were obtained. The 24 h urine protein excretion Results estimation and creatinine clearance were performed at least annually. On at least one occasion between January 1995 The mean duration of diabetes in the study group was and January 1996, each patient also had ambulatory BP 14.5 years (9-36 years) and the mean age was 54 years recording, using the SpacelabB 90207 ambulatory monitor (27-73). There was no significant difference in age (Spacelabs Medical, Redmond, USA) operated according to between the two groups. Median data acquisition for standard protocols (recordings every 15 min 0700-2200 and all patients was 6 years (1990) (1991) (1992) (1993) (1994) (1995) (1996) . Five patients every 30 min 2200-0700 [7] ); random office BP was >160/90 mmHg for all patients on at least one clinic visit in progressed to ESRF, requiring renal replacement the year preceding ABPM. Thus, all patients were considered therapy after the study period. None of the patients potentially to be hypertensive, and ABPM was performed to has died (see Table 1 ).
establish day and night BP levels, diurnal variability and any
The data suggest that the marked difference in DCrCl element of white-coat BP effect. The patients were asked to between the two groups is not a function of the clinic keep a diary of time asleep and other day-time activities (e.g. BP recordings as there was no significant difference physical activity/meals etc.). Diaries, and information from between them. The data from the ambulatory BP direct interrogation of each patient, were used to calculate recordings show no significant difference between the 23 for men therefore follows that the total 24 h blood pressure and 1.05 for women; these results were corrected for body load in the 'non-dipper' group was higher ( Table 1) . surface area (1.73m2) [8] . The DCrCl was calculated in each The distribution of DCrCl against dipper status is patient by plotting the regression line through serial creatindemonstrated in Figure 1. ine clearance estimates. The DCrCl was expressed in Patients who had repeat ambulatory BP recordings ml/min/year. GHb was estimated from serial 3-monthly estimates (GHb was measured using a high-affinity chromato-retained their diurnal rhythm pattern (whether normal or abnormal ) despite alterations in anti-hypertensive ory monitoring. The pulse rates (on ABPM ) are outlined in Table 2 . medication.
All 26 patients were on angiotensin-converting The prevalence of overt clinical (peripheral and autonomic) neuropathy was significantly (P<0.05) enzyme inhibitors; nine patients in the dipper group and 10 patients in the non-dipper group were on higher in those patients with abnormal BP diurnal rhythm. This is outlined in Table 3 . calcium channel blockers. Three patients in the dipper group and four in the non-dipper group received beta-blockers.
Discussion
Non-dipping had a significant (P<0.05) effect upon the DCrCl in these patients, in that in those patients with defective diurnal BP regulation, the period of Diabetic nephropathy is a condition characterized by relentless deterioration in renal function, heralded by time between diagnosis of DN and ERSF was shorter. Day/night pulse rate variability was significantly the development of microalbuminuria [10] ; many factors affect both the development of DN and its rate of (P<0.05) lower in the non-dipper group on ambulat- port in diabetics [22] . It would be statistically imprudent to attempt to analyse differences between min between the groups, and no difference in dietary instruction, a confounding explanation of the difference between the groups being due to different dietary progression. Here we have demonstrated that in those patients who have good glycaemic control and have protein intake is not likely; but a comprehensive evaluation of 6 years dietary habitus is not possible. good control of day-time clinic BP, night-time BP is a further important factor in the progression of this Similarly we do not think that the small numerical (non-significant) differences between the two groups nephropathy. Whether this is simply a function of greater 24 h blood pressure load or whether non-for metabolic/office BP parameters are likely to explain the degree of difference between the two groups. We dipping is a surrogate marker for worse diabetic complications is unclear from our retrospective data. could not find a continuous statistically significant relationship between decline in renal function and Relative elevation of night-time BP has been demonstrated in those patients who have autonomic neuro-awake-to-asleep BP differences; this is a weakness of a small retrospective study. The fact that when the two pathy [11] . Autonomic neuropathy has been shown to be a predictor for deterioration in glomerular filtration groups had ABPM performed their plasma creatinines were different is not likely to be relevant to the rate in IDDM [12] . Mulec et al. [13] , after studying extracellular fluid volume and ambulatory BP simul-difference in diurnal BP behaviour; any effect on diurnal BP rhythm from renal function is modest [23] . taneously, suggested that latent overhydration may contribute to nocturnal hypertension in diabetics.
Given the recent descriptions of the effect of ACE gene polymorphisms on progression of DN [24] , knowing In our study, we have demonstrated that abnormal BP rhythm indicated a poorer prognosis for the rate the prevalence of the 'D' genotype in each group would be of considerable interest, though no association of progression of DN. Those patients with abnormal BP diurnal rhythm had a greater prevalence of clinical between ACE gene polymorphism and sleep-related BP patterns has been described. neuropathy and also had reduced day/night pulse rate variation (P<0.05), again compatible with autonomic Patients with DN who have elevated night-time BP had a significantly increased DCrCl compared neuropathy. The ambulatory BP recordings, when repeated in our patients (n=12), did show good repro-with those with normal BP diurnal rhythm. Antihypertensive medication should be tailored to both ducibility, and all those patients who had abnormal BP diurnal rhythm on one recording retained it on day-time and night-time BP in these patients. There are no studies in the literature to show that specific repeat recordings. There are no data available on reproducibility of ABPM diurnal rhythm categoriz-targeting of night-time BP slows the rate of decline of renal function in DN, but in not measuring night-time ation in secondary hypertension, let alone for patients with abnormal renal function due to DN.
BP in these patients we may be missing a potential therapeutic target. How far to lower BP in these An interesting observation is the much greater 24 h pulse pressure value for the non-dipping patients. Pulse patients is also unknown [25] ; the dangers of excessive diastolic BP reduction are well known [26 ] . A prospectpressure is a surrogate for arterial distensibility [14] , itself influenced by several factors [15] ; abnormal ive interventional study is needed to resolve these issues. arterial structure and function is much reported in essential hypertension [16 ] , diabetes mellitus [17] and renal failure [18] . Failure of the large arteries to
